TY - JOUR
T1 - Association of Cancer History with Lifetime Risk of Dementia and Alzheimer’s Disease
AU - Li, Yaqi
AU - Xu, Xinming
AU - Wang, Peilu
AU - Chen, Xiqun
AU - Yang, Qishan
AU - Sun, Liang
AU - Gao, Xiang
N1 - Publisher Copyright:
© 2024 – IOS Press. All rights reserved.
PY - 2024/4/16
Y1 - 2024/4/16
N2 - Background: The literature presents conflicting results regarding the potential protective effect of prevalent cancer on the development of dementia and Alzheimer’s disease (AD). Objective: Association between cancer and subsequent risk of dementia and/or AD was reported previously, but survival bias has been of concern. Here, we aimed to calculate the lifetime risk of dementia and AD and evaluate the association of cancer history with these two conditions. Methods: In this retrospective analysis, we included 292,654 participants aged 60+ y during the follow-up and free of dementia at baseline, within the UK Biobank cohort. Lifetime risks of dementia and AD were estimated in individuals with and without cancer history, and different durations of cancer exposure and cancer types. Results: During a median of 12.5 follow-up years, 5,044 new dementia and 2,141 AD cases were reported. Lifetime risks of dementia and AD were lower in cancer survivors compared to those without cancer, and this effect was more pronounced in participants with cancer history exposure ≥ 5 years. Similar relationship was observed in individual cancer types, except for breast cancer. Conclusions: Results suggested an inverse association between cancer history and lifetime risk of dementia and AD, which may be modified by different cancer types and cancer exposure time.
AB - Background: The literature presents conflicting results regarding the potential protective effect of prevalent cancer on the development of dementia and Alzheimer’s disease (AD). Objective: Association between cancer and subsequent risk of dementia and/or AD was reported previously, but survival bias has been of concern. Here, we aimed to calculate the lifetime risk of dementia and AD and evaluate the association of cancer history with these two conditions. Methods: In this retrospective analysis, we included 292,654 participants aged 60+ y during the follow-up and free of dementia at baseline, within the UK Biobank cohort. Lifetime risks of dementia and AD were estimated in individuals with and without cancer history, and different durations of cancer exposure and cancer types. Results: During a median of 12.5 follow-up years, 5,044 new dementia and 2,141 AD cases were reported. Lifetime risks of dementia and AD were lower in cancer survivors compared to those without cancer, and this effect was more pronounced in participants with cancer history exposure ≥ 5 years. Similar relationship was observed in individual cancer types, except for breast cancer. Conclusions: Results suggested an inverse association between cancer history and lifetime risk of dementia and AD, which may be modified by different cancer types and cancer exposure time.
UR - http://www.scopus.com/inward/record.url?scp=85191104377&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85191104377&partnerID=8YFLogxK
U2 - 10.3233/JAD-231223
DO - 10.3233/JAD-231223
M3 - Article
C2 - 38517790
AN - SCOPUS:85191104377
SN - 1387-2877
VL - 98
SP - 1319
EP - 1328
JO - Journal of Alzheimer's Disease
JF - Journal of Alzheimer's Disease
IS - 4
ER -